| JAZZ PHARMACEUTICALS |
| Irland |
| Gesundheit |
| IE00B4Q5ZN47 / A1JS1K |
| J7Z (Frankfurt) / JAZZ (NASDAQ) |
| FRA:J7Z, ETR:J7Z, J7Z:GR, NASDAQ:JAZZ |
| - |
| http://www.jazzpharma.com.. |
|
Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing and commercializing medicines for serious and often underserved conditions. Its portfolio includes treatments for sleep disorders, epilepsy, oncology, and other spec..
>Volltext.. |
| 12562.5 Mio. EUR |
| 14499.88 Mio. EUR |
| 4122.82 Mio. EUR |
| 1499.01 Mio. EUR |
| 842.95 Mio. EUR |
| 13.67 EUR |
| 3950.84 Mio. EUR |
| 1451.38 Mio. EUR |
| 1488.33 Mio. EUR |
| 0.99 |
| 16.13% |
| - |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 1.661.930 Euro. |
| JAZZ PHARMACEUTICALS, JAZZ PHARMA |
| 01.11.26 |
|
||||
|
||||
|